633 related articles for article (PubMed ID: 16855188)
1. 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients.
Desbriere R; Vuaroqueaux V; Achard V; Boullu-Ciocca S; Labuhn M; Dutour A; Grino M
Obesity (Silver Spring); 2006 May; 14(5):794-8. PubMed ID: 16855188
[TBL] [Abstract][Full Text] [Related]
2. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
[TBL] [Abstract][Full Text] [Related]
3. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.
Paulsen SK; Pedersen SB; Fisker S; Richelsen B
Obesity (Silver Spring); 2007 Aug; 15(8):1954-60. PubMed ID: 17712112
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women.
Goedecke JH; Wake DJ; Levitt NS; Lambert EV; Collins MR; Morton NM; Andrew R; Seckl JR; Walker BR
Clin Endocrinol (Oxf); 2006 Jul; 65(1):81-7. PubMed ID: 16817824
[TBL] [Abstract][Full Text] [Related]
5. Deep subcutaneous adipose tissue: a distinct abdominal adipose depot.
Walker GE; Verti B; Marzullo P; Savia G; Mencarelli M; Zurleni F; Liuzzi A; Di Blasio AM
Obesity (Silver Spring); 2007 Aug; 15(8):1933-43. PubMed ID: 17712110
[TBL] [Abstract][Full Text] [Related]
6. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
[TBL] [Abstract][Full Text] [Related]
7. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss.
Engeli S; Böhnke J; Feldpausch M; Gorzelniak K; Heintze U; Janke J; Luft FC; Sharma AM
Obes Res; 2004 Jan; 12(1):9-17. PubMed ID: 14742837
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
Baudrand R; Domínguez JM; Carvajal CA; Riquelme A; Campino C; Macchiavello S; Bozinovic M; Morales M; Pizarro M; Solis N; Escalona A; Boza C; Arrese M; Fardella CE
Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348
[TBL] [Abstract][Full Text] [Related]
9. Omental 11beta-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity.
Michailidou Z; Jensen MD; Dumesic DA; Chapman KE; Seckl JR; Walker BR; Morton NM
Obesity (Silver Spring); 2007 May; 15(5):1155-63. PubMed ID: 17495191
[TBL] [Abstract][Full Text] [Related]
10. Depot-specific messenger RNA expression of 11 beta-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults.
Li X; Lindquist S; Chen R; Myrnäs T; Angsten G; Olsson T; Hernell O
Int J Obes (Lond); 2007 May; 31(5):820-8. PubMed ID: 17060929
[TBL] [Abstract][Full Text] [Related]
11. 11beta-hydroxysteroid dehydrogenase type 1 is overexpressed in subcutaneous adipose tissue of morbidly obese patients.
Muñoz R; Carvajal C; Escalona A; Boza C; Pérez G; Ibáñez L; Fardella C
Obes Surg; 2009 Jun; 19(6):764-70. PubMed ID: 18592327
[TBL] [Abstract][Full Text] [Related]
12. Expression of genes related to glucocorticoid action in human subcutaneous and omental adipose tissue.
Veilleux A; Laberge PY; Morency J; Noël S; Luu-The V; Tchernof A
J Steroid Biochem Mol Biol; 2010 Oct; 122(1-3):28-34. PubMed ID: 20206259
[TBL] [Abstract][Full Text] [Related]
13. Expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 enzyme in subcutaneous and visceral adipose tissue of prepubertal children.
Mericq V; Medina P; Bouwman C; Johnson MC; Godoy J; López T; Iñiguez G
Horm Res; 2009; 71(2):89-93. PubMed ID: 19129713
[TBL] [Abstract][Full Text] [Related]
14. Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state.
Nannipieri M; Bonotti A; Anselmino M; Cecchetti F; Madec S; Mancini E; Baldi S; Santini F; Pinchera A; Rossi M; Ferrannini E
Int J Obes (Lond); 2007 Dec; 31(12):1843-8. PubMed ID: 17607322
[TBL] [Abstract][Full Text] [Related]
15. Obesity is accompanied by disturbances in peripheral glucocorticoid metabolism and changes in FA recycling.
Simonyte K; Rask E; Näslund I; Angelhed JE; Lönn L; Olsson T; Mattsson C
Obesity (Silver Spring); 2009 Nov; 17(11):1982-7. PubMed ID: 19360009
[TBL] [Abstract][Full Text] [Related]
16. Expression of subcutaneous adipose tissue phosphoenolpyruvate carboxykinase correlates with body mass index in nondiabetic women.
Chang TJ; Lee WJ; Chang HM; Lee KC; Chuang LM
Metabolism; 2008 Mar; 57(3):367-72. PubMed ID: 18249209
[TBL] [Abstract][Full Text] [Related]
17. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
[TBL] [Abstract][Full Text] [Related]
18. 11Beta hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle.
Jang C; Obeyesekere VR; Dilley RJ; Alford FP; Inder WJ
Clin Endocrinol (Oxf); 2006 Dec; 65(6):800-5. PubMed ID: 17121533
[TBL] [Abstract][Full Text] [Related]
19. The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus.
Catalán V; Gómez-Ambrosi J; Rotellar F; Silva C; Gil MJ; Rodríguez A; Cienfuegos JA; Salvador J; Frühbeck G
Clin Endocrinol (Oxf); 2007 Apr; 66(4):598-601. PubMed ID: 17371481
[TBL] [Abstract][Full Text] [Related]
20. Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity.
Wake DJ; Strand M; Rask E; Westerbacka J; Livingstone DE; Soderberg S; Andrew R; Yki-Jarvinen H; Olsson T; Walker BR
Clin Endocrinol (Oxf); 2007 Mar; 66(3):440-6. PubMed ID: 17302881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]